Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

104.28 +0.43 (+0.41%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis Ag ADR

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
42 43 Next >
The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Entasis Announces Positive Data For Late-Stage Study Of SUL-DUR In... 
Via Benzinga
Great Place to Work® Announces the World’s Best Workplaces™ 2021
Great Place to Work® Announces the World’s Best Workplaces™ 2021 
Via News Direct
Acute Myeloid Leukemia (AML) Therapeutics market:Which Trend Will Emerge in Near Future? with Top Companies Like: Bristol-Myers Squibb, Novartis, Roche
This report is a compilation of a number of extensive, authentic research studies on the global Acute Myeloid Leukemia (AML) Therapeutics market that help the reader to gain profound knowledge of each... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
Lung Cancer Market Outlook 2021: Big Things Are Happening : Novartis, Pfizer, Merck
Stay up to date with Lung Cancer Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
United States Afinitor Market: Which Product Segment Will exhibit sluggish CAGR? with Top Companies Like Novartis
The report sheds light on future trends, key opportunities, top regions, leading segments, the competitive landscape, and several other aspects of the United States Afinitor market. Get access to... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
You can perch on a 1-legged stool and balance precariously on 2, but if you want to settle in with comfort and safety, you need 3 sturdy legs. With its secure, cloud-based... 
Via Benzinga
3 No-Brainer Stocks to Buy Right Now
These stocks are all trading near their 52-week lows, but they're all solid investments to hold over the long term. 
Via The Motley Fool
Global Pediatric Vaccines Market Size Is Projected to Reach Us$ 45100 Million by 2027, from Us$ 29730 Million in 2020, at a Cagr of 5.7% During 2021-2027
The global Pediatric Vaccines market is extensively evaluated by seasoned research analysts to help readers to expand their market knowledge and become aware of future market changes ahead of time. 
Via SBWire
Global Medical Device Market to Register a Moderate CAGR of 5.2% for the Predicted Period
Los Angeles, CA -- (SBWIRE) -- 10/13/2021 -- QY Research has published a report titled, "Global Medical Device Industry Research Report Growth Trends and Competitive Analysis 2019-2025" to offer an... 
Via SBWire
Topics Initial Public Offering
Exposures Product Safety Securities Market
Will Crispr Stock — And Its Cancer Drug — Rise After Allogene's Massive Fall?
Crispr is planning to begin a registrational test in the first quarter of 2022. 
Via Investor's Business Daily
Global Rizatriptan Market: How Can a Player Gain a Competitive Edge? Merck, Pfizer, Novartis (Sandoz)
QY Research has used its tons of research and analysis experience and deeper knowledge to comprehensively study the global Rizatriptan market. This report promises sound market understanding for better... 
Via SBWire
Global Biologic Drugs Market: What Is Challenging Market Growth? with Top Companies Like: Johnson & Johnson, Merck & Co., Pfizer
Global Biologic Drugs Market : Buyers of the report have access to crucial findings and important data on the global Biologic Drugs market. Players can simply use the report to gain the upper hand in... 
Via SBWire
Kidney Cancer Market May See Big Move : Bristol-Myers Squibb, Pfizer, Roche
Stay up-to-date with Kidney Cancer Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Biosimilars Market Worth $44.7 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global biosimilars market is projected to reach $44.7 billion by 2026. Biosimilars Products Market Report provides crucial industry insights that will help your business grow." /> 
Via SBWire
Topics Intellectual Property
Exposures Intellectual Property
eFFECTOR Therapeutics Stock Gains On Encouraging Preclinical Zotatifin Data In Breast Cancer
eFFECTOR Therapeutics Inc (NASDAQ: EFTR), in collaboration with Baylor College of Medicine, announced the presentation of new positive data for zotatifin in... 
Via Benzinga
Women's Health Care Market Worth $17.8 Billion – Global Industry Segments and Leading Key Players
The global women’s healthcare market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period 
Via SBWire
Global Measles Market: What Risk Will Market Face in Future? with Top Companies Like: Abbott, Biomedical Diagnostics, Johnson & Johnson Services
The report helps players and investors to stay in a competent position in the global Measles market as they gain insights into the market competition, leading segments, top regions, and other vital... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
Cannabis Movers & Shakers: TOCC, 1933 Industries, Iter Investments, Greenlane
Former Tilray Exec Steven Yoo Named Texas Original Compassionate Cultivation's New CFO Texas medical cannabis provider,&n... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Global Antibiotics Drugs Market: Which Application Willgain the Lion'S Share? with Top Companies Like:Johnson & Johnson, Sanofi-Aventis, Enanta Pharmaceuticals
QY Research has used its tons of research and analysis experience and deeper knowledge to comprehensively study the global Antibiotics Drugs market. This report promises sound market understanding for... 
Via SBWire
Global Sex Hormones Market: Which Country Will Create the Highest Demand? with Top Companies Like:Novartis, Merck, Sanofi
This report is a compilation of a number of extensive,authentic research studies on the global Sex Hormones market that help the reader to gain profound knowledge of each and every aspect of the... 
Via SBWire
September Update: The Conservative Pot Stocks Index Continued To Outperform
Reticent about investing in the seed-to-sale sector? Perhaps you should consider investing in more conservative cannabis-related companies, which have lost less YTD. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Global Megestrol Industry Analysis and Trends Forecast to 2027:Pfizer, Sandoz, GSK
The global Megestrol market is extensively evaluated by seasoned research analysts to help readers to expand their market knowledge and become aware of future market changes ahead of time. 
Via SBWire
Global Biological Drugs Industry Analysis Report 2021:Bristol-Myers Squibb, Eli Lilly, Takeda
Buyers of the report have access to crucial findings and important data on the global Biological Drugs market. Players can simply use the report to gain the upper hand in the market competition. 
Via SBWire
Global Biosimilars Industry Analysis Report 2021:Pfizer, Novartis, Biocon
The new report on the global Biosimilars market comes out as an extremely useful resource that helpsplayers to gain a competitive edge over their toughest competitors. It can be customized as per... 
Via SBWire
Death Cross Looms Over Novartis Investors
If history is any guide, there may be trouble ahead for shares of Novartis(NYSE:NVS). A so-called "death cross" has formed on its chart and, not surprisingly, this could... 
Via Benzinga
A Bit Of A Recovery
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week. 
Via Talk Markets
Novartis and Medicines for Malaria Venture Report Positive Results for Phase 2b Study of Novel Ganaplacide/Lumefantrine Combination in Children With Malaria
SOURCE: Novartis 
Via 3BL Media
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Novartis Posts New Data Reinforcing Efficacy, Convenience Of Cosentyx Autoinjector In Psoriasis
Novartis AG (NYSE: NVS) announced data from an international Phase 3b study of Cosentyx (secukinumab) in plaque psoriasis. Data showed that treatment with Cosentyx... 
Via Benzinga
This Potential Indication Could Be a Winner for Novartis
The U.S. Food and Drug Administration accepted Novartis' filing for tislelizumab to treat esophageal cancer. 
Via The Motley Fool
Exposures Product Safety
African Research Foundation Partners With International Pharmaceutical Industry to Strengthen Capacity for Health Innovation in Africa
SOURCE: International Federation of Pharmaceutical Manufacturers & Associations 
Via 3BL Media
Exposures COVID-19
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.